The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $1.69 for the day, down -2.87% from the previous closing price of $1.74. In other words, the price has decreased by -$2.87 from its previous closing price. On the day, 1.88 million shares were traded. INO stock price reached its highest trading level at $1.795 during the session, while it also had its lowest trading level at $1.66.
Ratios:
Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.79 and its Current Ratio is at 0.79.
Upgrades & Downgrades
In the most recent recommendation for this company, Piper Sandler on July 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $5.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $20.
Oppenheimer Upgraded its Perform to Outperform on January 25, 2024, while the target price for the stock was maintained at $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 116108712 and an Enterprise Value of 49753168. For the stock, the TTM Price-to-Sale (P/S) ratio is 645.06. Its current Enterprise Value per Revenue stands at 272.864 whereas that against EBITDA is -0.564.
Stock Price History:
The Beta on a monthly basis for INO is 1.63, which has changed by -0.124352336 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, INO has reached a high of $2.98, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is -20.10%, while the 200-Day Moving Average is calculated to be -15.58%.
Shares Statistics:
INO traded an average of 1.38M shares per day over the past three months and 2117170 shares per day over the past ten days. A total of 68.70M shares are outstanding, with a floating share count of 68.42M. Insiders hold about 0.42% of the company’s shares, while institutions hold 40.93% stake in the company. Shares short for INO as of 1765756800 were 9445637 with a Short Ratio of 6.85, compared to 1763078400 on 8259257. Therefore, it implies a Short% of Shares Outstanding of 9445637 and a Short% of Float of 13.8.
Earnings Estimates
Current recommendations for the stock of the company come from 4.0 analysts. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.33 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$2.31 and -$2.41 for the fiscal current year, implying an average EPS of -$2.35. EPS for the following year is -$1.49, with 5.0 analysts recommending between -$1.06 and -$1.95.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $65k, resulting in an average revenue estimate of $82.5k. In the same quarter a year ago, actual revenue was $217.76kBased on 6 analysts’ estimates, the company’s revenue will be $15.97M in the next fiscal year. The high estimate is $41.5M and the low estimate is $7.9M.
